These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14734586)

  • 1. Antibiotics and coronary heart disease.
    Modest GA; Kaufmann J
    JAMA; 2004 Jan; 291(3):302; author reply 303. PubMed ID: 14734586
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotics and coronary heart disease.
    Nieto FJ
    JAMA; 2004 Jan; 291(3):302-3; author reply 303. PubMed ID: 14734587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES].
    Pokrovskaia EV
    Kardiologiia; 2004; 44(10):82-3. PubMed ID: 15477798
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlamydia pneumoniae and acute coronary syndrome.
    Wong BY; Gnarpe J
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16079381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
    Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 7. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
    O'Connor CM; Dunne MW; Pfeffer MA; Muhlestein JB; Yao L; Gupta S; Benner RJ; Fisher MR; Cook TD;
    JAMA; 2003 Sep; 290(11):1459-66. PubMed ID: 13129985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection.
    Hammerschlag MR
    Circulation; 2002 Oct; 106(15):e65-6; author reply e65-6. PubMed ID: 12370232
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.
    Gelfand EV; Cannon CP
    Am Heart J; 2004 Feb; 147(2):202-9. PubMed ID: 14760314
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlamydia pneumoniae infection in Slovenian patients with diffuse coronary artery disease.
    Zorc M; Kese D; Petrovic D; Legan M
    Med Arh; 2004; 58(6):331-4. PubMed ID: 15648226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for coronary disease: it's time to move on.
    Conti CR
    Clin Cardiol; 2004 Dec; 27(12):669. PubMed ID: 15628106
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial.
    Hilden J; Lind I; Kolmos HJ; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Jensen GB; Kastrup J; Kjøller E; Nielsen H; Petersen L; Jespersen CM; Gluud C;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):385-92. PubMed ID: 20226329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
    Muhlestein JB
    Curr Atheroscler Rep; 2000 Jul; 2(4):336-41. PubMed ID: 11122763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?
    Anderson JL
    N Engl J Med; 2005 Apr; 352(16):1706-9. PubMed ID: 15843674
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS).
    Chandra HR; Choudhary N; O'Neill C; Boura J; Timmis GC; O'Neill WW
    Am J Cardiol; 2001 Aug; 88(3):214-8. PubMed ID: 11472696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapy for coronary artery disease: can a WIZARD change it all?
    Pislaru SV; Van de Werf F
    JAMA; 2003 Sep; 290(11):1515-6. PubMed ID: 13129994
    [No Abstract]   [Full Text] [Related]  

  • 17. Low prevalence of antibodies against heat shock protein 10 of Chlamydophila pneumoniae in patients with coronary heart disease.
    Ciervo A; Petrucca A; Villano U; Fioroni G; Cassone A
    J Microbiol Methods; 2005 Dec; 63(3):248-53. PubMed ID: 15893396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide treatment after coronary stent placement.
    Arzt M; Pfeifer M; Holmer S; Riegger G
    Lancet; 2001 Dec 22-29; 358(9299):2168-9. PubMed ID: 11784661
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.